Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
9960429 | Journal of the American College of Cardiology | 2005 | 5 Pages |
Abstract
While atorvastatin 80 mg was superior to pravastatin 40 mg in terms of achieving the dual goals of aggressive LDL-C and CRP reduction, neither agent brought the majority of patients below thresholds needed to maximize patient benefit.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
Paul M. MD, David A. MD, Lynda M. MS, Nader PhD, Christopher P. MD, Eugene MD,